Avivagen Inc. Announces the Granting of Options

By , in PR PR Health on .

OTTAWA, Dec. 22, 2017 — Avivagen Inc. (TSX-V:VIV) (OTC Pink:CHEXF) (“Avivagen” or the “Company”), a life sciences innovation company with a series of patent protected products that support and optimize human and animal health, announces the granting of 60,000 options to a corporation controlled by a director of the Company. These options are granted pursuant to a consulting agreement between the Company and such corporation.The options, which shall be vested over an eight-quarter period, are exercisable up to five years from the issuing date, and have a strike price of $0.90.Option grants are subject to the approval of the TSX Venture Exchange.About Avivagen
Avivagen Inc. is a public Company traded on the TSX Venture Exchange under the symbol VIV and is headquartered in Ottawa, Canada, based in partnership facilities of the National Research Council of Canada and Charlottetown, Prince Edward Island. For more information, visit www.avivagen.com.

The following two tabs change content below.
Brad Bennett

Brad Bennett

Brad grew up in a small town in northern Iowa. He studied chemistry in college, graduated, and married his wife one month later. They were then blessed with two baby boys within the first four years of marriage. Having babies gave their family a desire to return to the old paths – to nourish their family with traditional, homegrown foods; rid their home of toxic chemicals and petroleum products; and give their boys a chance to know a simple, sustainable way of life. They are currently building a homestead from scratch on two little acres in central Texas. There’s a lot to be done to become somewhat self-sufficient, but they are debt-free and get to spend their days living this simple, good life together with their five young children.
%d bloggers like this: